Richard Law

Stock Analyst at Goldman Sachs

(0.55)
# 2641
Out of 5,441 analysts
65
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
15 Stocks
Name Action PT Current % Upside Ratings Updated
VRDN Viridian Therapeutic...
Maintains: Strong Buy
27 30
16.9 77.51% 4 Aug 7, 2025
MLTX MoonLake
Maintains: Strong Buy
74 82
53.36 53.67% 4 Aug 6, 2025
OLMA Olema Pharmaceutical...
Maintains: Buy
20 18
4.57 293.87% 5 May 14, 2025
RCKT Rocket Pharmaceutica...
Maintains: Neutral
15 13
2.93 343.69% 3 May 9, 2025
CLDX Celldex Therapeutics
Maintains: Neutral
36 31
20.01 54.92% 3 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 24
13.2 81.82% 6 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
11
4.18 163.16% 4 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
31
11.13 178.53% 2 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
46 47
17.16 173.89% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
62 63
55.44 13.64% 6 Aug 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
36 37
37.69 -1.83% 8 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
76
10.75 606.98% 6 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
36
0.93 3770.97% 4 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
15 14
2.2 536.36% 3 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
61
6.58 827.05% 4 May 8, 2023